- Patent Title: Glucono delta-lactone for treatment of vaginal fungal infections
-
Application No.: US17218739Application Date: 2021-03-31
-
Publication No.: US11696891B2Publication Date: 2023-07-11
- Inventor: Ulf Ellervik , Olov Sterner , Helena Strevens , Sophie Manner
- Applicant: Gedea Biotech AB
- Applicant Address: SE Lund
- Assignee: Gedea Biotech AB
- Current Assignee: Gedea Biotech AB
- Current Assignee Address: SE Lund
- Agency: Dinsmore & Shohl LLP
- Agent Weston R. Gould
- Priority: SE 504672 2016.04.06
- Main IPC: A61K9/00
- IPC: A61K9/00 ; A61K31/366 ; F27D1/16 ; F27B14/10 ; F27B14/06 ; A61P31/10 ; A61K9/02 ; H05B6/24 ; A61K9/20 ; A61K31/351 ; A61K31/4164 ; A61K31/496 ; A61K31/513 ; A61K31/7004 ; F27B14/00 ; F27B3/12 ; A61K31/4174 ; A61K31/4196 ; F27B14/08
Abstract:
The present invention relates to a pharmaceutical formulation for vaginal administration, wherein the formulation comprises a pharmaceutical acceptable excipient and glucono δ-lactone, wherein the glucono δ-lactone is present in an amount of 5 to 99 wt % of the formulation. The invention also relates to a pharmaceutical formulation according to the invention for use in the prevention or treatment of a urogenital fungal infection. Furthermore, the invention relates to glucono δ-lactone (formula (III)), for use in the in the prevention or treatment of a fungal infection.
Public/Granted literature
- US20210212937A1 GLUCONO DELTA-LACTONE FOR TREATMENT OF VAGINAL FUNGAL INFECTIONS Public/Granted day:2021-07-15
Information query
